4//SEC Filing
GTC BIOTHERAPEUTICS INC 4
Accession 0001180955-05-000017
CIK 0000904973operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:19 PM ET
Size
9.3 KB
Accession
0001180955-05-000017
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Common Stock
2005-02-15+6,459→ 47,562 total - Award
Common Stock (right to buy)
2005-02-15+39,000→ 39,000 totalExercise: $1.71Exp: 2015-02-15→ Common Stock (39,000 underlying)
Holdings
- 10,486(indirect: By 401(k))
Common Stock
- 0(indirect: By Son)
Common Stock
Footnotes (3)
- [F1]Shares of the Issuer's common stock were awarded to the Reporting Person in lieu of a portion of what would otherwise have been cash bonus compensation for fiscal year 2004.
- [F2]The Reporting Person no longer has a reportable interest in shares of the Issuer's common stock owned by his son and included in the Reporting Person's prior ownership reports.
- [F3]7,800 options vested on February 15, 2005, the remaining 31,200 options vest in equal annual installments on each of February 15, 2006, 2007, 2008 and 2009.
Documents
Issuer
GTC BIOTHERAPEUTICS INC
CIK 0000904973
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000904973
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:19 PM ET
- Size
- 9.3 KB